CLINICAL_TRIALS
trial_result
· 2010-05-10
Clinical Trial Update: Randomized, Placebo-Controlled Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia [Phase 3]
Summary
Phase 3 randomized, placebo-controlled study of abobotulinumtoxinA (Dysport) for cervical dystonia completed with results posted in 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ipsen | Conditions: Cervical Dystonia | Phase 3 | Status: COMPLETED | Results posted: 2010-05-10